1. Home
  2. RWAY vs LAB Comparison

RWAY vs LAB Comparison

Compare RWAY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Runway Growth Finance Corp.

RWAY

Runway Growth Finance Corp.

N/A

Current Price

$6.70

Market Cap

274.5M

Sector

N/A

ML Signal

N/A

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

N/A

Current Price

$0.73

Market Cap

257.2M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
RWAY
LAB
Founded
2015
1999
Country
United States
United States
Employees
N/A
389
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
274.5M
257.2M
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
RWAY
LAB
Price
$6.70
$0.73
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $8.11
N/A
AVG Volume (30 Days)
291.0K
★ 758.9K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
★ 20.27%
N/A
EPS Growth
N/A
★ 61.54
EPS
0.08
★ 0.29
Revenue
N/A
★ $101,937,000.00
Revenue This Year
$2.98
N/A
Revenue Next Year
$1.40
N/A
P/E Ratio
$83.06
★ $2.26
Revenue Growth
★ N/A
N/A
52 Week Low
$5.19
$0.59
52 Week High
$9.62
$1.72

Technical Indicators

Market Signals
Indicator
RWAY
LAB
Relative Strength Index (RSI) 55.85 62.71
Support Level $6.31 $0.71
Resistance Level $6.85 $0.79
Average True Range (ATR) 0.19 0.04
MACD 0.03 0.01
Stochastic Oscillator 81.76 90.33

Price Performance

Historical Comparison
RWAY
LAB

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: